Institutional investors purchased a net $1.8 million shares of ANTH during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 51.23% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CUTLER GROUP LP Bought 4.3 Thousand shares of Anthera Pharmaceuticals I...